What is the appropriate management of insomnia in an older adult with dementia?

Management of Insomnia in Dementia

Prioritize non-pharmacological interventions first, specifically cognitive-behavioral therapy for insomnia (CBT-I) adapted for dementia patients, combined with sleep hygiene measures and environmental modifications, as these provide sustained benefits with minimal harm compared to medications that carry significant risks in this vulnerable population.

Treatment Algorithm

First-Line: Non-Pharmacological Approaches

The evidence strongly supports starting with behavioral interventions, as they provide longer-term sustained benefits and avoid the substantial risks of medications in older adults with dementia 1.

Sleep Hygiene and Environmental Modifications 1:

• Maintain consistent bed and wake times daily, regardless of sleep obtained
• Limit time in bed to actual sleep time (sleep restriction/compression)
• Use bedroom only for sleep and sex—no TV, work, or stimulating activities
• Leave bedroom if unable to fall asleep within 20 minutes; return only when sleepy
• Limit daytime napping to maximum 30 minutes before 2 PM
• Avoid caffeine, nicotine, and alcohol, especially evening use
• Avoid heavy exercise within 2 hours of bedtime
• Ensure bedroom is dark, quiet, and comfortable temperature

Stimulus Control Therapy 1:

• Establish 30-minute pre-bedtime relaxation ritual
• Strengthen association between bed/bedroom and sleep only
• Eliminate arousing activities from bedroom environment

CBT-I Adapted for Dementia 2: Sleep disturbances in dementia include not just insomnia but also hypersomnia, excessive nocturnal motor activity, and behavioral problems. CBT-I principles should be implemented through caregivers who can oversee treatment recommendations. The 2021 Alzheimer's & Dementia guidelines note that while CBT-I has robust evidence in older adults generally, specific studies in dementia populations are limited, requiring caregiver involvement for successful implementation 2.

Additional Non-Pharmacological Strategies 2, 3:

• Bright light therapy: Helps regulate circadian rhythm disruption common in dementia
• Increased daytime physical activity: Aerobic exercise shows consistent medium effect sizes for cognition and may improve sleep
• Sleep-wake schedule regulation: Critical given suprachiasmatic nucleus degeneration in Alzheimer's disease
• Decreased evening arousal: Minimize stimulating activities before bedtime

Second-Line: Pharmacological Options (When Non-Pharmacological Insufficient)

Critical Caveat: Medications should be started at the lowest dose and used cautiously, as older adults with dementia have increased sensitivity to adverse effects including falls, cognitive impairment, and mortality risk 1.

Preferred Pharmacological Options (based on most recent evidence):

1. Low-dose Orexin Receptor Antagonists 4, 5:

   • Lemborexant 2.5 mg shows most favorable profile for nocturnal awakenings in recent 2026 systematic review
   • Dual orexin receptor antagonists recommended for older adults with insomnia 5

2. Eszopiclone 4:

   • Recent evidence (2026) shows small-to-large benefits with significant improvements in sleep efficiency and latency
   • Among Z-drugs, demonstrates most favorable outcomes

3. Low-dose Doxepin 5:

   • Recommended option for older adults
   • Lower risk profile than traditional sedative-hypnotics

4. Melatonin/Ramelteon 1, 5:

   • Melatonin receptor agonists show no significant abuse potential or motor/cognitive impairment
   • Addresses circadian rhythm dysfunction common in dementia

Medications to AVOID 1, 6:

• Antipsychotics: Should be deprescribed if used for insomnia—no systematic evidence of effectiveness and risks outweigh benefits 6. The 2018 Canadian guideline specifically recommends deprescribing antipsychotics for primary insomnia or secondary insomnia where comorbidities are managed.
• Antihistamines, antidepressants (except low-dose doxepin), anticonvulsants: NIH concluded risks outweigh benefits for off-label insomnia treatment 1
• Traditional benzodiazepines: Higher adverse effect frequency/severity than newer agents; increased fall risk, cognitive impairment, and dependence 1

Combination Therapy

When behavioral interventions alone are insufficient, combining CBT-I with carefully selected pharmacotherapy provides superior short-term outcomes, though behavioral therapy sustains improvements better long-term 1. One RCT in older adults showed combination therapy more efficacious than either modality alone, with medications providing rapid relief while behavioral therapy maintains long-term benefit.

Key Clinical Considerations

Dementia-Specific Sleep Pathophysiology 2, 7:

• Alzheimer's disease and frontotemporal dementia: Circadian rhythm disturbances from suprachiasmatic nucleus degeneration
• Dementia with Lewy bodies: REM sleep behavior disorder predominates
• Decreased melatonin secretion across dementia types
• Sleep disturbances worsen cognitive decline, agitation, delirium, and nighttime wandering

Common Pitfalls to Avoid:

• Starting with medications instead of behavioral interventions
• Using antipsychotics for insomnia management
• Failing to involve caregivers in treatment implementation
• Not addressing underlying medical comorbidities contributing to insomnia
• Inadequate trial duration of non-pharmacological approaches before adding medications

Caregiver Involvement: Essential for success, as patients with dementia cannot independently implement sleep hygiene or CBT-I strategies 2. Improving sleep reduces caregiver burden and delays institutionalization 8.

Impact on Outcomes: Successful insomnia management in dementia improves quality of life, reduces fall risk, decreases daytime sleepiness, and may slow cognitive decline 1. The bidirectional relationship between insomnia and dementia risk underscores the importance of aggressive treatment 9, 10.